X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A coalition of law firms went to court across the nation Tuesday, trying to force the pharmaceutical industry to study whether vaccines containing a trace of mercury cause autism and other brain damage in young children. The lawsuits were filed as class actions and led by an Oregon woman who says her 2-year-old son, William, became autistic after getting vaccinations containing the mercury-containing preservative, thimerosal. “We had a happy, healthy little boy until that last set of shots,” Tory Mead said. “It’s been devastating. Our lives have been shattered.” Michael Williams, the lead attorney, said drug companies did not tell doctors how much mercury was contained in the vaccines until Congress ordered the Food and Drug Administration to find out in 1997. “When they added it up, they were shocked to find out it was way above the safe level for an adult, let alone babies or very young children,” Williams said. He said thimerosal was used simply as a way to reduce the cost of the vaccine. It was needed to preserve larger bottles that would be used repeatedly. If the drug companies had offered the vaccine in small, disposable vials for individual use, no preservative would have been needed, Williams said. Today, few vaccines given to children in the United States contain thimerosal. The suit seeks to make sure any remaining stocks are removed. The law firm representing Mead formed a coalition of more than 35 law firms across the country representing families in at least 25 states. The suits’ immediate goal is getting the industry to study whether the mercury caused the brain problems; damages could be sought if such a link is established. Spokesmen for the firms said the lawsuits were being filed Tuesday in nine states — California, Connecticut, Maine, Maryland, New Hampshire, Pennsylvania, Virginia, Washington and West Virginia. Suits already have been filed in Oregon and Massachusetts. The lawsuits were announced the day after the National Academy of Sciences released a report saying researchers still are unable to determine if there is a link between thimerosal and disorders in children. But the report concluded that “the effort to remove thimerosal from vaccines was a prudent measure in support of the public health goal to reduce the mercury exposure of infants and children as much as possible.” In July 1999, the American Academy of Pediatrics joined the U.S. Public Health Service to warn that vaccines containing thimerosal should be removed as soon as possible. The defendants in the lawsuits include Aventis Pasteur Inc.; Pasteur Merieux Connaught; Pfizer Inc., a subsidiary of Warner-Lambert; GlaxoSmithKline; Merck & Co.; Abbott Laboratories; American Home Products; Wyeth-Ayerst Laboratories; Lederle Laboratories; Baxter International Inc., Eli Lilly & Co.; Integra Chemical Co.; Sigma Chemical Co.; and Aldrich Chemical Co. Three doctors involved in the care of Mead’s son also were named as defendants. Spokeswomen for Merck and Abbot had no comment. Calls to other defendants were not immediately returned. Copyright 2001 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.